Assertio Therapeutics, INC (ASRT): Hi ATLcitizen! Good to see you here. I t...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	3
Posts	281
Boards Moderated	0
Alias Born	12/21/2022

dcaf7

Re: ATLcitizen post# 190

Saturday, 12/23/2023 10:21:18 AM

Saturday, December 23, 2023 10:21:18 AM

Hi ATLcitizen! Good to see you here. I think physicians view Ryzneuta the same way as Rolvedon. No clear differentiation from Neulasta. Assertio should work on same day dosing. As for Poziotinib, I don't know. I don't see any new trials with Pozi but I see several drug candidates in development that are less toxic. I found interesting document describing what exactly Spectrum did to be acquired. It looks like Hanmi was considering to buy Spectrum.
https://www.sec.gov/Archives/edgar/data/1808665/000110465923071264/tm2315184-6_s4a.htm
This acquisition story is described on pp71-82 step by step. Board was interested to sell the company when TR became a CEO. "Following the appointment of Thomas J. Riga as Spectrum’s President and Chief Executive Officer effective January 1, 2022, the Spectrum board of directors engaged in discussions regarding potential strategic alternatives at each of its regularly scheduled meetings and authorized Mr. Riga and the Spectrum management team to explore potential strategic alternatives".